13F HOLDINGS REPORT
Decheng Capital LLC
Quarter ended Q1 2024 · Filed May 14, 2024 · Accession 0001104659-24-060707
Total Value
$745.6M
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Alpine Immune Sciences, Inc. | 02083G100 | 8,317,924 | $329.7M | 44.22% |
| 2 | CG ONCOLOGY INC | CGON | 5,458,810 | $239.6M | 32.14% |
| 3 | Zentalis Pharmaceuticals Inc. | ZNTL | 2,099,583 | $33.1M | 4.44% |
| 4 | Illumnia, Inc. | ILMN | 129,067 | $17.7M | 2.38% |
| 5 | BeyondSpring Inc. | BYSI | 4,958,143 | $17.7M | 2.37% |
| 6 | Arcus Biosciences, Inc | RCUS | 869,790 | $16.4M | 2.20% |
| 7 | KRYSTAL BIOTECH INC | KRYS | 65,772 | $11.7M | 1.57% |
| 8 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 347,835 | $11.1M | 1.49% |
| 9 | Equillium Inc. | EQ | 4,447,308 | $10.3M | 1.38% |
| 10 | PHATHOM PHARMACEUTICALS INC | PHAT | 850,000 | $9.0M | 1.21% |
| 11 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 166,600 | $8.4M | 1.12% |
| 12 | CRINETICS PHARMACEUTICALS IN | CRNX | 157,958 | $7.4M | 0.99% |
| 13 | 10x Genomics, Inc. | TXG | 195,835 | $7.3M | 0.99% |
| 14 | CYTOKINETICS INC | CYTK | 94,043 | $6.6M | 0.88% |
| 15 | LEGEND BIOTECH CORP-ADR | LEGN | 86,363 | $4.8M | 0.65% |
| 16 | MERUS NV | N5749R100 | 101,798 | $4.6M | 0.61% |
| 17 | Aura Biosciences, Inc. | AURA | 515,555 | $4.0M | 0.54% |
| 18 | Cue Health Inc. | 229790100 | 8,980,909 | $1.7M | 0.23% |
| 19 | Pyxis Oncology, Inc (formerly Apexigen) | PYXS | 326,810 | $1.4M | 0.19% |
| 20 | Aadi Bioscience, Inc. | WHWK | 526,329 | $1.2M | 0.17% |
| 21 | GeneDx Holdings Corp. | WGSWW | 103,604 | $945,904 | 0.13% |
| 22 | AtriCure Inc. | ATRC | 26,797 | $815,165 | 0.11% |